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Abstract
Renal oncocytoma is a benign tumor with clinical features mimicking 
renal cell carcinoma. We present a 63-year-old man with a typical case of 
oncocytoma with specific image findings on computed tomography and 
angiography. Radical nephrectomy remains the appropriate diagnosis and 
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Renal oncocytoma was first described by Zippel in 
1942 [1], and it accounts for 3–7% of all solid renal 
neoplasms [2]. In 2004, the World Health Organiza-
tion defined oncocytoma as a benign renal epithelial 
tumor with a histological composition of large cells 
(oncocytes) with a mitochondria-rich cytoplasm. It is 
important to distinguish oncocytoma from renal cell 
carcinoma (RCC), which has a poor prognosis. The 
treatment for renal oncocytoma is also different from 
that for RCC. However, the diagnosis of renal oncocy-
toma is usually made after surgical removal of the 
tumor because of a lack of specific clinical features 
and imaging findings [3]. We present here a case with 
specific imaging findings of oncocytoma.
2. Case report
Our patient was a 63-year-old man with a history of 
hypertension for 4 years. He had gross hematuria for 
1 week in October 2008. The physical examination was 
normal except for a grade III systolic heart murmur. 
Chest radiography showed cardiomegaly. Laboratory 
screening tests were normal except for hyperurice-
mia. However, a urine examination showed numerous 
red blood cells per high power field. An abdominal 
ultrasound and renal computed tomography (CT) scan 
showed a homogeneous 5.5 × 5 cm mass in the upper 
left kidney, with the central part showing diminished 
contrast uptake (Fig. 1A). No pararenal lymph node 
enlargement was observed. Renal artery angiography 
showed a hypervascular tumor without a definite ar-
teriovenous fistula (Fig. 1B). After evaluation of his 
cardiac function, the patient underwent left radical 
nephrectomy via a flank approach.
Macroscopically, there was one well-defined, non-
encapsulated, brownish tumor measuring 6 cm in the 
greatest dimension confined to the renal parenchyma. 
A central stellate scar in the center of the tumor with-
out necrosis or infiltration of the renal vein was ob-
served. The renal pelvis was compressed but was not 
involved by the tumor (Fig. 1C). Microscopically, the 
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tumor had a morphological presentation of an onco-
cytoma with a small lobular growth of regular round 
cells with bland nuclei. The cytoplasm was eosino-
philic with fine granulation (Fig. 1D).
3. Discussion
Renal oncocytoma is a benign renal epithelial neo-
plasm comprising 3–5% of all primary epithelial neo-
plasms in the adult kidney [4]. Up to two thirds of 
patients are asymptomatic and the majority of these 
tumors are detected during a routine check-up for uri-
nary tract infection or prostate disease [5]. The most 
common presenting symptoms are abdominal pain, 
a palpable mass and macroscopic hematuria. The 
age at presentation is between 40 and 60 years. The 
male to female predominance is 2–3:1. Tumors have 
an average size of 6 cm [3]. A renal oncocytoma is 
usually solitary, but bilateral and multifocal tumors 
have been noted. Most of the tumors are sporadic, 
but there are some inherited cases. Coexisting RCC 
is diagnosed in 2–32% of cases [6]. Renal oncocytoma 
is a benign tumor, which does not metastasize, and it 
has an excellent prognosis.
Clinically, the differential diagnosis between onco-
cytoma and RCC is important because the character-
istics of oncocytoma parallel those of RCC including 
sex distribution, peak occurrence, tumor size and clin-
ical symptoms [7]. In this case, the patient was inves-
tigated for gross hematuria and his characteristics 
coincided with those for oncocytoma.
Current state-of-the-art CT and magnetic resonance 
imaging technology may permit improved detection 
and better characterization of these two types of 
renal tumors. CT of an oncocytoma usually reveals a 
solid homogeneity of the lesion with a central stel-
late area of low density, whereas RCC often presents 
Fig. 1 — (A) Computed tomography shows a 5.5 × 5 cm left solid renal mass, which is well-defined with a central hy-
podense region (arrow). (B) Renal arterial angiography shows a hypervascular tumor with a spoke-wheel pattern. No 
arteriovenous fistula formation is seen. (C) Grossly, the tumor is solid, brownish and well-defined with central scar 
formation. No central necrosis is seen. (D) Microscopically, the tumor has abundant small lobular growth of round cells 
with bland nuclei and eosinophilic cytoplasm.
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as a heterogeneous tumor with central necrosis. On 
magnetic resonance imaging, most oncocytomas dem-
onstrate low signal intensity relative to the renal cor-
tex on T1-weighted images. Two thirds of cases have 
high signal intensity on T2-weighted images [8]. This 
is very different from RCC where there is usually a 
medium-to-high intensity signal on T1 and a high in-
tensity signal on T2. Renal arterial angiography shows 
a spoke-wheel vascular pattern and absence of neo-
plastic vessels. However, oncocytomas are indistin-
guishable from RCCs by imaging studies alone. These 
characteristics may suggest but cannot definitively 
diagnose oncocytoma. Our patient presented with typ-
ical images of oncocytoma on CT, although in most 
cases the central stellate area cannot be differentiated 
from central necrosis seen in RCC. Angiography in our 
patient also showed the characteristic spoke-wheel 
vascular pattern.
On microscopic examination, renal oncocytomas 
are composed of uniform round or polygonal eosino-
philic cells, most commonly arranged in a nested or 
organoid growth pattern. There are atypical features 
including prominent nucleoli, conspicuous pleomor-
phism, cellular atypia, and hemorrhage or extension 
into the perinephric fat. However, it is not well ac-
cepted that tumors with these atypical features are 
oncocytomas [9].
Although a definite diagnosis can be made by renal 
biopsy, it is performed much less often in renal tu-
mors than in other tumors such as those of the breast, 
prostate or liver. This is because of the difficulty in 
differentiation of oncocytoma from the granular form 
of conventional RCC or eosinophilic variants of chro-
mophobe or chromophilic RCC. Another reason is 
that coexisting RCC is commonly diagnosed in onco-
cytoma in the same lesion, or at other locations in 
the same kidney [9]. Currently, the most acceptable 
treatment for oncocytoma is radical nephrectomy. 
The reason for using radical nephrectomy is the uncer-
tainty of the benign nature of oncocytoma before 
surgical intervention. A radical operation might be 
considered over-treatment [3], and therefore, a partial 
nephrectomy with nephron-sparing surgery is now con-
sidered the standard of treatment for oncocytoma, 
especially for those with a well-circumscribed solid 
tumor smaller than 4 cm with a typical central stellate 
scar on CT and no signs of metastases [5]. If the tumor 
is larger than 4 cm, malignancy is still possible [10]. 
The reasons for carrying out radical nephrectomy in 
this case were the difficulty in making a diagnosis 
based on the clinical features and imaging findings 
before surgery, and a tumor size over 4 cm.
In conclusion, our case had a typical oncocytoma 
presentation, although preoperative evaluation did not 
establish a definite diagnosis. Specific imaging find-
ings including CT, magnetic resonance imaging and 
angiography permit a more precise approach but the 
reliability remains controversial. Radical nephrectomy 
remains the appropriate treatment for solid renal tu-
mors of uncertain origin, whether benign or malignant. 
A partial nephrectomy is another appropriate alter-
native if oncocytoma is diagnosed, especially for small 
tumors with typical image findings. Overall, renal on-
cocytoma behaves as a benign tumor, and the long-
term prognosis is excellent.
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